LABA/LAMA vs ICS/LABA for exacerbations - Management of Stable COPD - GOLD COPD 2017 Resource Center: Activity Five
MSC1551 NAC Asthma COPD Medications Chart 2018 HR Internal | PDF | Drugs | Pharmaceutical Sciences
Nuovi dati su ICS/LABA/LAMA vs LABA/LAMA per la BPCO • NCF
effect of laBa/laMa versus laMa or laBa/ICs on safety outcomes | Download Table
COPD Inhalers - Easy to Use Reference Tool - CommPharm Consulting
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Page 14 - Rivista SIMG 1 - Maggio 2023 - web
ICS/LABA/LAMA si dimostra superiore a LABA/LAMA per la BPCO • NCF
Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis | Respiratory Research | Full Text
Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD: Cohort Study in Real-World Clinical Practice - ScienceDirect
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study - The Lancet Respiratory Medicine
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a | COPD
Pharmaceuticals | Free Full-Text | Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
Chronic obstructive pulmonary disorder (COPD) inhaler criteria - Province of British Columbia
Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
Adding a LAMA to ICS/LABA Therapy: A Meta‐analysis of Triple Combination Therapy in COPD | Semantic Scholar
Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study - ScienceDirect
LAMA/LABA therapy reduced risk for COPD exacerbation, pneumonia hospitalization
Figure 1 from LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes | Semantic Scholar
ICS/LABA/LAMA per la BPCO è stata approvata in Europa • NCF
A new alphabet for COPD care | European Respiratory Society
Follow Up Treatment | Stiolto® Respimat® Inhalation Spray | HCP
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study | Archivos de Bronconeumología
INCONTRI CON L'ESPERTO – BPCO:ICS, LAMA, LABA – Comitato Regionale Friuli Venezia Giulia
